A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.
Experimental Drug Gaining Popularity Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these profiles directly for source information, while also obtaining discount codes.
Thriving Commerce on Social Networks
Additionally, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting substances of unknown origin.
Several professionals said the popularity for the experimental drug could be connected to the rising price of licensed weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or Telegram is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.
Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and customer regulations, potentially leading to fines, prosecution or prison.
Service Response and Material Removal
According to TikTok, the platform has removed problematic material and prohibited associated hashtags and search suggestions. The organization said it was dedicated to maintaining the platform secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Research also found communities with up to nine thousand members selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of slimming results, glowing reviews and step-by-step guides for mixing or injecting at home.
After minutes of entering one community, a vendor posted WhatsApp details, where most transactions occur. The seller sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.
Product Details and Pricing
Within these groups, messages display dark colored packages with postal service stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how much time a pen should last, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram stated it actively monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Even if the science behind this drug is valid, these digital versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she explained.
Her staff has already encountered individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly significant health risks”.
